14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.0060 $169.56 Wednesday, 19th Apr 2023 CLVS stock ended at $0.151. During the day the stock fluctuated 0% from a day low at $0.151 to a day high of $0.151.
90 days $113.65 $133.77
52 weeks $171.20 $133.77

Historical Clovis Oncology prices

Date Open High Low Close Volume
Mar 18, 2021 $5.59 $5.63 $5.29 $5.32 4 867 965
Mar 17, 2021 $5.50 $5.74 $5.42 $5.72 4 096 516
Mar 16, 2021 $5.90 $5.92 $5.54 $5.61 5 150 651
Mar 15, 2021 $6.01 $6.07 $5.77 $5.88 3 749 410
Mar 12, 2021 $6.02 $6.16 $5.88 $5.94 4 333 327
Mar 11, 2021 $6.02 $6.30 $5.91 $6.25 5 495 314
Mar 10, 2021 $6.05 $6.20 $5.76 $5.87 7 328 564
Mar 09, 2021 $5.53 $6.09 $5.44 $5.99 6 842 940
Mar 08, 2021 $5.62 $5.80 $5.33 $5.42 4 806 414
Mar 05, 2021 $5.67 $5.78 $5.04 $5.58 8 702 927
Mar 04, 2021 $5.63 $6.07 $5.52 $5.66 11 748 735
Mar 03, 2021 $5.78 $5.84 $5.50 $5.55 7 272 223
Mar 02, 2021 $6.29 $6.35 $5.70 $5.72 10 473 355
Mar 01, 2021 $6.16 $6.41 $6.04 $6.23 4 594 198
Feb 26, 2021 $6.00 $6.18 $5.82 $5.99 6 781 451
Feb 25, 2021 $6.51 $6.91 $5.90 $5.94 12 217 911
Feb 24, 2021 $6.13 $6.22 $6.01 $6.20 5 605 752
Feb 23, 2021 $6.29 $6.50 $5.75 $6.01 10 105 354
Feb 22, 2021 $6.61 $7.03 $6.53 $6.68 7 657 477
Feb 19, 2021 $6.80 $6.99 $6.60 $6.65 6 888 177
Feb 18, 2021 $7.00 $7.06 $6.65 $6.67 8 622 471
Feb 17, 2021 $7.07 $7.80 $6.91 $7.12 14 206 018
Feb 16, 2021 $8.00 $8.00 $7.08 $7.16 11 094 163
Feb 12, 2021 $8.51 $8.60 $7.85 $7.90 9 499 213
Feb 11, 2021 $9.61 $9.68 $8.55 $8.60 11 212 955
Click to get the best stock tips daily for free!

About Clovis Oncology

Clovis Oncology Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer, as well as for metastatic castration-resistant prostate cancer. In Europe, the... CLVS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT